貴州百靈(002424.SZ):已完成全國32個省、市及自治區營銷網絡的覆蓋
格隆匯6月15日丨有投資者向貴州百靈(002424.SZ)提問:公司銷售模式是怎樣的?
貴州百靈回覆:公司業務主要分為臨牀藥品銷售業務和OTC藥品銷售業務。臨牀業務主要通過招商代理開展,即公司——省級/區域代理商——醫院的銷售模式;OTC業務主要通過公司自有營銷團隊開展,即銷售部(各省級區域辦事處)——商業公司——藥房、診所終端等銷售模式。公司通過打造全渠道營銷平台,已完成全國32個省、市及自治區營銷網絡的覆蓋,積極推進OTC和處方藥的市場推廣和學術推廣工作。
公司通過分析終端客户需求情況的不同,結合公司產品的特點,針對商業批發企業、各等級醫院、連鎖藥店、單體藥店、診所和基層醫療機構、電商平台的特點,通過做好渠道細分規劃,積極推進各渠道團隊的建設,加大產品的學術推廣及培訓體系的建設,制訂出適合不同市場的銷售方式和激勵政策,加強自建銷售隊伍的發展。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.